Sogol Mostoufi-Moab Research Program

Led by Sogol Mostoufi-Moab, MD, researchers in the Mostoufui-Moab Research Program are studying the long term late effects of hematopoietic stem transplantation (HSCT) on pediatric patients with benign and malignant hematologic disorders. Previous studies in the Mostoufi-Moab program showed that allogeneic hematopoietic stem-cell transplantation (alloHSCT) survivors treated with total body irradiation (TBI) exhibit bone deficits and excess adiposity which can contribute to long term late treatment effects such as impaired glucose metabolism and increased risk of insulin resistance.

Selected Publications

Premature epiphyseal closure of the lower extremities contributing to short stature after cis-retinoic acid therapy in medulloblastoma: A case report. Hormone Res Paediatr, October 13, 2015.
Noyes JJ, Levine MA, Mostoufi-Moab S.

Insulin-like growth Factor-1 and adiponectin and associations with muscle deficits, disease characteristics, and treatments in rheumatoid arthritis. J Rheumatol. 2015 Nov;42(11):2038-45.
Baker JF, Von Feldt JM, Mostoufi-Moab S, Kim W, Taratuta E, Leonard MB.

Pediatric thyroid carcinoma in patients with graves disease: The role of ultrasound in selecting patients for definitive therapy. Horm Res Paediatr. 2015 Apr 15. [Epub ahead of print]
Kovatch KJ, Bauer AJ, Isaacoff EJ, Prickett KK, Adzick NS, Kazahaya K, Sullivan LM, Mostoufi-Moab S.